文献速递呼吸道感染呼吸危重症与机械通气

COVID-19相关肺炎患者在ICU外接受无创呼吸支持的可行性与临床影响

Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia.
PubMed 文献 · Eur Respir J · 2020-11-05

这项观察性研究分析了意大利九家医院2020年3月1日至5月10日收治的670例确诊COVID-19患者,评估在ICU外应用无创呼吸支持(NRS)的可行性、结局及医护人员感染风险。结果显示NRS在ICU外可行且结局良好,但存在医护人员污染风险;调整混杂因素后死亡相对概率与所用NRS模式无关。

要点

  • ICU外应用NRS(HFNC、CPAP、NIV)可行,但需关注医护人员感染风险。
  • 总体30天未调整死亡率为26.9%,HFNC、CPAP、NIV分别为16%、30%、30%。
  • 调整混杂因素后,死亡相对概率与所用NRS模式无关。

核心结论

  • 在ICU外应用无创呼吸支持是可行的,并与有利结局相关,但伴随医护人员污染风险。

研究设计与样本

  • 观察性研究,纳入2020年3月1日至5月10日意大利九家医院呼吸科病房的670例连续确诊COVID-19患者。

主要发现

  • 42名(11.1%)医护人员新冠病毒检测阳性,其中仅3人需住院。
  • 全部患者平均±标准差年龄为68±13岁,69.3%为男性,基线PaO2/FiO2为152±79。
  • 49.3%的患者接受CPAP治疗;总体未调整30天死亡率为26.9%,HFNC、CPAP、NIV分别为16%、30%、30%。
  • 总插管率为27%,HFNC、CPAP、NIV分别为29%、25%、28%;调整混杂因素后死亡相对概率与NRS模式无关。
  • 插管率和住院时间在各组间无差异;死亡率随年龄和合并症等级进展而增加。

临床怎么用

  • 在ICU外可考虑应用HFNC、CPAP或NIV支持COVID-19相关肺炎患者,但需加强医护人员防护。
  • 选择NRS模式时,死亡相对概率与模式无关,可结合患者耐受性和资源条件个体化决定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The severe acute respiratory syndrome-coronavirus 2 outbreak spread rapidly in Italy and the lack of intensive care unit (ICU) beds soon became evident, forcing the application of noninvasive respiratory support (NRS) outside the ICU, raising concerns over staff contamination. We aimed to analyse the safety of the hospital staff and the feasibility and outcomes of NRS applied to patients outside the ICU. METHODS: In this observational study, data from 670 consecutive patients with confirmed coronavirus disease 2019 referred to pulmonology units in nine hospitals between March 1 and May 10, 2020 were analysed. Data collected included medication, mode and usage of NRS (i.e. high-flow nasal cannula (HFNC), continuous positive airway pressure (CPAP), noninvasive ventilation (NIV)), length of stay in hospital, endotracheal intubation (ETI) and deaths. RESULTS: 42 (11.1%) healthcare workers tested positive for infection, but only three of them required hospitalisation. Data are reported for all patients (69.3% male), whose mean±sd age was 68±13 years. The arterial oxygen tension/inspiratory oxygen fraction ratio at baseline was 152±79, and the majority (49.3%) of patients were treated with CPAP. The overall unadjusted 30-day mortality rate was 26.9%, with 16%, 30% and 30% for HFNC, CPAP and NIV, respectively, while the total ETI rate was 27%, with 29%, 25% and 28%, respectively; the relative probability of death was not related to the NRS used after adjustment for confounders. ETI and length of stay were not different among the groups. Mortality rate increased with age and comorbidity class progression. CONCLUSIONS: The application of NRS outside the ICU is feasible and associated with favourable outcomes. Nonetheless, it was associated with a risk of staff contamination.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Franco C, Facciolongo N, Tonelli R, et al. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J. 2020. PMID: 32747398. doi:10.1183/13993003.02130-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。